Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Vaccinations01:51

Vaccinations

Overview
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Establishment of a Neonatal Natural Transmission Model for CMV Vaccine Development.

The Journal of infectious diseases·2026
Same author

Dynamics of Respiratory Syncytial Virus Illness and Serology During Pregnancy and Infancy in the United States and South Africa.

Open forum infectious diseases·2025
Same author

Author Correction: BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.

Nature·2025
Same author

A Statistical Model to Predict Protection Against Infant Respiratory Syncytial Virus Disease Through Maternal Immunization.

Vaccines·2025
Same author

Toxicologic Pathology Forum: mRNA Vaccine Safety-Separating Fact From Fiction.

Toxicologic pathology·2024
Same author

RSV Prefusion F Protein-Based Maternal Vaccine - Preterm Birth and Other Outcomes.

The New England journal of medicine·2024

Related Experiment Video

Updated: Jun 14, 2026

Influenza Virus Propagation in Embryonated Chicken Eggs
06:56

Influenza Virus Propagation in Embryonated Chicken Eggs

Published on: March 19, 2015

H1N1: can a pandemic cycle be broken?

Ethan C Settembre1, Philip R Dormitzer, Rino Rappuoli

  • 1Novartis Vaccines and Diagnostics, Cambridge, MA 02139, USA.

Science Translational Medicine
|April 9, 2010
PubMed
Summary

Glycosylation altered the 1918 pandemic influenza virus (H1N1) in swine, creating seasonal flu strains distinct from the original. This research offers insights for preventing future influenza pandemics.

Area of Science:

  • Virology
  • Immunology
  • Glycobiology

Background:

  • The 2009 H1N1 pandemic influenza virus shares antigenic similarities with the 1918 pandemic strain.
  • The human population developed susceptibility to a swine-archived, modified 1918 H1N1 influenza virus.
  • Seasonal human flu viruses are immunologically distinct from their 1918 and 2009 pandemic precursors.

Purpose of the Study:

  • To elucidate the mechanisms by which glycosylation influences influenza virus evolution.
  • To understand how glycosylation leads to immunologically distinct seasonal flu strains.
  • To identify strategies for anticipating and preventing future influenza pandemics.

Main Methods:

  • Comparative analysis of viral glycosylation patterns.
  • Immunological assays to assess strain distinctness.

More Related Videos

Development of Multiplex Real-Time RT-qPCR Assays for the Detection of SARS-CoV-2, Influenza A/B, and MERS-CoV
03:53

Development of Multiplex Real-Time RT-qPCR Assays for the Detection of SARS-CoV-2, Influenza A/B, and MERS-CoV

Published on: November 10, 2023

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
08:10

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

Published on: January 15, 2020

Related Experiment Videos

Last Updated: Jun 14, 2026

Influenza Virus Propagation in Embryonated Chicken Eggs
06:56

Influenza Virus Propagation in Embryonated Chicken Eggs

Published on: March 19, 2015

Development of Multiplex Real-Time RT-qPCR Assays for the Detection of SARS-CoV-2, Influenza A/B, and MERS-CoV
03:53

Development of Multiplex Real-Time RT-qPCR Assays for the Detection of SARS-CoV-2, Influenza A/B, and MERS-CoV

Published on: November 10, 2023

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
08:10

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

Published on: January 15, 2020

  • Mechanistic studies on the role of glycosylation in viral adaptation.
  • Main Results:

    • Glycosylation significantly modifies the antigenic properties of the H1N1 influenza virus.
    • Evolutionary pathways driven by glycosylation result in seasonal strains divergent from pandemic precursors.
    • The 1918 pandemic virus, when archived in swine, underwent glycosylation changes leading to distinct seasonal variants.

    Conclusions:

    • Glycosylation is a key mechanism driving the antigenic drift of influenza viruses, leading to distinct seasonal strains.
    • Understanding these glycosylation-driven evolutionary changes is crucial for predicting and mitigating future influenza pandemics.
    • This research provides a mechanistic basis for developing novel pandemic preparedness strategies.